We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01065662
First Posted: February 9, 2010
Last Update Posted: May 8, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
National Comprehensive Cancer Network
Wyeth is now a wholly owned subsidiary of Pfizer
AstraZeneca
Information provided by (Responsible Party):
Susana M. Campos, MD, Dana-Farber Cancer Institute
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2018
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)